Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila

被引:21
作者
Chau, Katy Wing-Kam
Chan, Wood-Yee
Shaw, Pang Chui
Chan, Ho-Yin Edwin [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Mol Biotechnol Programme, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Lab Drosophila Res, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Anat, Shatin, Hong Kong, Peoples R China
关键词
Alzheimer's disease; Cdk5; GSK3; beta; PHF; pre-tangles;
D O I
10.1016/j.bbrc.2006.05.112
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tau hyperphosphorylation and insoluble aggregate formation are two cellular features of tauopathies. However, the contribution of Tau protein hyperphosphorylation and its aggregation to Tau pathology still remain controversial. Overexpression of human tau transgenes in the Drosophila eye is toxic and causes neuronal degeneration. We showed that human Tau protein was phosphorylated by endogenous protein kinases in flies, and overexpression of either GSK3 beta or Cdk5 enhanced tau-induced toxicity. Using a dominant-negative approach, we showed that kinase activity is important for the enhancement of tau-induced toxicity. Interestingly, such enhancement was accompanied with hyperphosphorylation and alteration of protein solubility properties of Tau. This situation was reminiscent of that observed in pre-tangle neurons in tauopathies patients. We also observed age-dependent Tau aggregate formation in aged transgenic flies. In summary, tau-induced toxicity is enhanced when the human Tau protein undergoes hyperphosphorylation, and we further demonstrated that aging contributes to Tau aggregate formation. Our data also underscore the utilization of transgenic Drosophila Tau models for the studies of pre-tangle events in tauopathies. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 47 条
[1]  
Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73
[2]   Targeted increase in shaggy activity levels blocks wingless signaling [J].
Bourouis, M .
GENESIS, 2002, 34 (1-2) :99-102
[3]   TAU-PROTEIN FUNCTION IN LIVING CELLS [J].
DRUBIN, DG ;
KIRSCHNER, MW .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2739-2746
[4]   Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation [J].
Ferrer, I ;
Pastor, P ;
Rey, MJ ;
Muñoz, E ;
Puig, B ;
Pastor, E ;
Oliva, R ;
Tolosa, E .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (01) :23-34
[5]   Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration [J].
Ferrer, I ;
Barrachina, M ;
Puig, B .
ACTA NEUROPATHOLOGICA, 2002, 104 (06) :583-591
[6]   Tau is not normally degraded by the proteasome [J].
Feuillette, S ;
Blard, O ;
Lecourtois, M ;
Frébourg, T ;
Campion, D ;
Dumanchin, C .
JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 80 (03) :400-405
[7]   Filamentous nerve cell inclusions in neurodegenerative diseases:: tauopathies and α-synucleinopathies [J].
Goedert, M .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :1101-1118
[8]   EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES TO THE PAIRED HELICAL FILAMENTS OF ALZHEIMERS-DISEASE - IDENTIFICATION OF PHOSPHORYLATION SITES IN TAU-PROTEIN [J].
GOEDERT, M ;
JAKES, R ;
CROWTHER, RA ;
COHEN, P ;
VANMECHELEN, E ;
VANDERMEEREN, M ;
CRAS, P .
BIOCHEMICAL JOURNAL, 1994, 301 :871-877
[9]   THE ALZHEIMER-LIKE PHOSPHORYLATION OF TAU-PROTEIN REDUCES MICROTUBULE BINDING AND INVOLVES SER-PRO AND THR-PRO MOTIFS [J].
GUSTKE, N ;
STEINER, B ;
MANDELKOW, EM ;
BIERNAT, J ;
MEYER, HE ;
GOEDERT, M ;
MANDELKOW, E .
FEBS LETTERS, 1992, 307 (02) :199-205
[10]   Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs [J].
Hernández, F ;
Pérez, M ;
Lucas, JJ ;
Avila, J .
BRAIN RESEARCH, 2002, 935 (1-2) :65-72